A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma

Clinical trial NCT01882803 · COMPLETED

Trial details

NCT number: NCT01882803
Sponsor: SecuraBio
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent Non-Hodgkin Lymphoma

Start date: 2013-06-17
Primary completion: 2020-11-18
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.